ACAD ACADIA Pharmaceuticals Inc. - Common Stock
$30,66
Fiyat · Ağu 19, 2026
Temel veriler itibarıyla Ağu 5, 2026
52 Haftlık Aralık
$20–$31
98% of range
Analist Derecelendirmesi
BUY
27 analysts
Fiyat Hedefi
$34
+10% upside
P/E (TTM)
13.3
ROE
38.1%
Net Kâr Marjı
36.5%
ACADIA Pharmaceuticals Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California.
Devamını oku
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California.
Product development
Nuplazid, a drug developed by Acadia in the late 1990s, "was designed to stimulate a subset of the brain’s serotonin receptors, or the proteins that govern memory, cognition and learning." On April 29, 2016, the FDA approved Acadia's drug, Nuplazid, for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. Nuplazid is the trade name for Acadia's proprietary molecule, pimavanserin, a selective serotonin inverse agonist preferentially targeting 5-HT2a receptors. Acadia had partnered with Biovail in the late-stage clinical testing of the drug, which showed trial failures as of 2009.
Acadia is running multiple Phase 2 and Phase 3 trials with pimavanserin in several central nervous system conditions: dementia-related psychosis, major depressive disorder, schizophrenia inadequate response, and schizophrenia negative symptoms.
As of 1997, Acadia was among several companies that licensed compounds from Genzyme's small-molecule compound library.
In 2023, the FDA approved trofinetide (marketed as Daybue) for use in Rett syndrome.
History
Acadia started in 1993 as Receptor Technologies, based in Winooski, Vermont. In 1997, the company relocated all operations and management from Vermont to San Diego, California, as a strategic move to garner partnerships with other biotechnology companies. However, the company also had an office in Denmark, in which it received a crucial part of its early investments from BankInvest, under managing director Florian Schönharting, Kommunernes Pensionsforsikring A/S and Dansk Kapitalanlæg Aktieselskab as well as private investor Lars Christiansen. At the time, the company had fifty employees, fourteen of whom were in the Denmark office. The focus of the company in its early years was on genetic screens for receptors, aiming to accelerate early stage drug discovery.
The company planned to conduct an initial public offering (IPO) consisting of 31.6% of the company in 2001, with the intention of raising US$64 million and listing on the NASDAQ exchange under the symbol ACAD. At the time, Acadia and Allergan were collaborating on development of a treatment for glaucoma, and Allergan would retain a 6.3% ownership stake in Acadia after the IPO. However, the company's IPO, which ultimately took place in May 2004, did not fare as well as expected and netted only US$35 million. At the time, the company had five drugs in development and was running two in human trials. The company had a subsequent round of stock offering in May 2007 which raised US$102 million.
In September 2020, Acadia Pharmaceuticals acquired clinical-stage biotechnology company CerSci Therapeutics.
Corporate governance
In 2001, the company's chief executive officer at the time, Leonard R. Borrmann, left Acadia to lead Maret Pharmaceuticals. He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016.
== References ==
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
ACAD Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$30.66
Piyasa Değeri
$5.22B
P/E (TTM)
13.3
EPS (TTM)
$2.30
Gelir (TTM)
$1.07B
Temettü Verimi
—
ROE
38.1%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$20 – $31
ACAD Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$1.07B
2016-12-31
→
2025-12-31
Hisse Başına Kâr
$2.30
2020-12-31
→
2025-12-31
Serbest Nakit Akışı
$105M
2016-12-31
→
2025-12-31
Marjlar
36.5%
2016-12-31
→
2023-12-31
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
ACAD
Akran Ortalaması
P/E (TTM)
13.3
13.2
P/S (TTM) (F/S (TTM))
4.9
55.3
P/B (F/D)
4.3
3.5
Price / FCF (Fiyat / Serbest Nakit Akışı)
49.7
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
ACAD
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
9.8%
—
Net Profit Margin (Net Kâr Marjı)
36.5%
-151.2%
ROA
28.4%
-42.2%
ROE
38.1%
-52.8%
ROIC
24.0%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
ACAD
Akran Ortalaması
Current Ratio (Cari Oran)
3.8
10.3
Quick Ratio (Cari Oran)
1.1
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
ACAD
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
11.9%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
27.5%
—
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
19.4%
—
EPS YoY (EPS YB)
69.1%
—
Net Income YoY (Net Gelir Yıllık Bazda)
72.7%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
ACAD
Akran Ortalaması
ACAD Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
27 analist
- Güçlü Al 7 25,9%
- Al 14 51,9%
- Tut 5 18,5%
- Sat 1 3,7%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
20 analist · 2026-08-18
Medyan
$36.00
Şimdi
$30.66
Düşük
$17.00
Yüksek
$49.00
Medyan hedef
$36.00
+17,4%
Ortalama hedef
$33.85
+10,4%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.30%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $0.18 | $0.06 | 0.12% |
| 31 Mart 2026 | $0.02 | $0.06 | -0.04% |
| 31 Aralık 2025 | $1.60 | $0.14 | 1.5% |
| 30 Eylül 2025 | $0.42 | $0.15 | 0.27% |
| 30 Haziran 2025 | $0.16 | $0.14 | 0.02% |
| 31 Mart 2025 | $0.11 | $0.11 | -0.00% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | — |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | — |
| ERAS | $1.06B | -8.5 | — | — | -35.7% | — |
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | — |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | — |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | — |
| DYN | $3.23B | -5.6 | — | — | -57.8% | — |
| PBLS | — | — | — | — | — | — |
| CELC | $4.81B | -26.3 | — | — | -244.3% | — |
| RLAY | $1.47B | -5.3 | 53.4% | -1800.6% | -44.9% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 16
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.07B | $958M | $726M | $517M | $484M | $442M | $339M | $224M | $125M | $17M | $61.0K | $120.0K | |
| Cost of Revenue | $89M | $82M | $42M | $10M | $19M | $10M | $11M | $12M | $9M | $3M | · | · | |
| Gross Profit | · | · | $685M | $507M | $473M | $432M | $328M | $211M | $116M | $14M | · | · | |
| R&D Expense | $329M | $303M | $352M | $362M | $239M | $319M | $240M | $187M | $149M | $99M | $74M | $61M | |
| SG&A Expense | $549M | $488M | $407M | $369M | $396M | $389M | $326M | $266M | $255M | $186M | $88M | $33M | |
| Operating Expenses | $967M | $727M | $800M | $741M | $655M | $728M | $586M | $471M | $417M | $290M | $165M | $93M | |
| Operating Income | $105M | $231M | $-73M | $-224M | $-170M | $-287M | $-247M | $-247M | $-292M | $-273M | $-165M | $-93M | |
| Other Non-op | $2M | $2M | $5M | $4M | $2M | $-997.0K | $997.0K | $-2M | · | · | · | · | |
| Pretax Income | $139M | $258M | $-51M | $-213M | $-168M | $-281M | $-234M | $-244M | $-288M | $-270M | $-164M | $-92M | |
| Income Tax | $-252M | $32M | $10M | $3M | $351.0K | $611.0K | $876.0K | $1M | $1M | $1M | $330.0K | $0 | |
| Net Income | $391M | $226M | $-61M | $-216M | $-168M | $-282M | $-235M | $-245M | $-289M | $-271M | $-164M | $-92M | |
| EPS (Basic) | $2.32 | $1.37 | $-0.37 | $-1.34 | $-1.05 | $-1.79 | · | · | · | · | · | · | |
| EPS (Diluted) | $2.30 | $1.36 | $-0.37 | $-1.34 | $-1.05 | $-1.79 | · | · | · | · | · | · | |
| Shares (Basic) | 168,356,000 | 165,717,000 | 163,819,000 | 161,683,000 | 160,493 | 157,331 | · | · | · | · | · | · | |
| Shares (Diluted) | 169,919,000 | 166,362,000 | 163,819,000 | 161,683,000 | 160,493 | 157,331 | · | · | · | · | · | · | |
| EBITDA | $105M | $231M | $-73M | $-224M | $-170M | $-287M | $-247M | $-247M | $-292M | $-273M | $-165M | $-93M |
Bilanço 25
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $178M | $320M | $189M | $115M | $147M | $326M | $190M | $135M | $69M | $164M | $102M | $62M | |
| Receivables | $121M | $99M | $98M | $62M | $64M | $48M | $36M | $26M | $17M | $6M | · | · | |
| Inventory | $111M | $92M | $40M | $12M | $14M | $10M | $6M | $4M | $5M | $4M | · | · | |
| Prepaid Expense | $60M | $56M | $39M | $21M | $24M | $26M | $19M | $21M | $8M | $8M | $2M | $1M | |
| Current Assets | $1.06B | $938M | $616M | $508M | $618M | $718M | $760M | $526M | $373M | $548M | $219M | $325M | |
| PP&E (Net) | $8M | $4M | $5M | $6M | $8M | $9M | $3M | $3M | $3M | $3M | $2M | $553.0K | |
| PP&E (Gross) | $17M | $14M | $14M | $14M | $14M | $13M | $9M | $8M | $7M | $6M | $5M | $3M | |
| Accum. Depreciation | $9M | $10M | $10M | $8M | $6M | $4M | $5M | $4M | $4M | $3M | $3M | $2M | |
| Intangibles | $109M | $120M | $65M | $0 | $0 | $1M | $3M | $4M | $6M | $7M | · | · | |
| Other Non-current Assets | $4M | $359.0K | $476.0K | $8M | $4M | $2M | $3M | $2M | $354.0K | $785.0K | $329.0K | $287.0K | |
| Total Assets | $1.56B | $1.19B | $749M | $588M | $700M | $783M | $783M | $540M | $385M | $561M | $222M | $325M | |
| Accounts Payable | $11M | $16M | $18M | $13M | $7M | $8M | $7M | $3M | $9M | $4M | $2M | $2M | |
| Accrued Liabilities | $266M | $379M | $237M | $113M | $89M | $97M | $68M | $56M | $40M | $36M | $20M | $14M | |
| Current Liabilities | $277M | $395M | $254M | $126M | $96M | $106M | $75M | $60M | $49M | $43M | $22M | $16M | |
| Capital Leases | $41M | $42M | $48M | $53M | $56M | $44M | $6M | · | · | · | · | · | |
| Deferred Tax | $11M | $11M | $12M | $13M | $14M | $13M | $3M | · | · | · | · | · | |
| Other Non-current Liabilities | $19M | $18M | $15M | $9M | $7M | $5M | $3M | $2M | · | · | · | · | |
| Total Liabilities | $337M | $455M | $317M | $187M | $159M | $156M | $84M | $61M | $49M | $43M | $22M | $16M | |
| Common Stock | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $15.0K | $14.0K | $12.0K | $12.0K | $10.0K | $10.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | $1.45B | $862M | $808M | |
| Retained Earnings | $-1.81B | $-2.20B | $-2.43B | $-2.37B | $-2.15B | $-1.99B | $-1.70B | $-1.47B | $-1.22B | $-934M | $-663M | $-498M | |
| AOCI | $1M | $292.0K | $24.0K | $-975.0K | $-192.0K | $36.0K | $297.0K | $-372.0K | $-399.0K | $106.0K | $11.0K | $-9.0K | |
| Stockholders' Equity | $1.23B | $733M | $432M | $400M | $541M | $627M | $699M | $479M | $335M | $518M | $200M | $309M | |
| Liabilities + Equity | $1.56B | $1.19B | $749M | $588M | $700M | $783M | $783M | $540M | $385M | $561M | $222M | $325M | |
| Shares Outstanding | 170,309,376 | 166,708,856 | 164,650,219 | 162,064,872 | 161,012,695 | 159,637,771 | 155,275,300 | 143,853,597 | 124,410,552 | 121,367,169 | 101,938,702 | 100,047,331 |
Nakit Akışı 13
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $206.0K | |
| Stock-based Comp | $52M | $67M | $66M | $68M | $64M | $84M | $82M | $82M | $76M | $55M | $40M | $16M | |
| Deferred Tax | $-250M | $0 | $0 | $3M | $351.0K | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $11M | $15M | $4M | $0 | $1M | $1M | $1M | $1M | $1M | $985.0K | $0 | $0 | |
| Operating Cash Flow | $110M | $158M | $17M | $-114M | $-126M | $-136M | $-151M | $-167M | $-218M | $-208M | $-122M | $-66M | |
| CapEx | $5M | $523.0K | $50.0K | $0 | $1M | $8M | $1M | $2M | $812.0K | $2M | $2M | $180.0K | |
| Investing Cash Flow | $-303M | $-31M | $32M | $73M | $-71M | $193M | $-166M | $-71M | $92M | $-262M | · | · | |
| Stock Issued | $50M | $7M | $25M | $8M | $18M | $81M | $372M | $307M | $31M | $519M | $15M | $204M | |
| Net Stock Activity | $50M | $7M | $25M | $8M | $18M | $81M | $372M | $307M | $31M | $519M | $15M | $204M | |
| Financing Cash Flow | $50M | $7M | $25M | $8M | $18M | $81M | $372M | $307M | $31M | $534M | · | · | |
| Net Change in Cash | $-143M | $134M | $74M | $-33M | $-179M | $137M | $55M | $68M | $-94M | $63M | $40M | $50M | |
| Taxes Paid | $25M | $20M | $6M | $2M | $1M | $1M | $2M | $1M | $1M | $-365.0K | $415.0K | · | |
| Free Cash Flow | $105M | $157M | $17M | $-114M | $-127M | $-144M | $-152M | $-170M | $-219M | $-212M | $-124M | $-67M |
Kârlılık 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 94.3% | 98.0% | 97.8% | 97.7% | 96.7% | 94.5% | 92.7% | 82.2% | · | · | |
| Operating Margin | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% | -64.9% | -72.7% | -110.6% | -234.1% | -1574.1% | -269855.7% | -77691.7% | |
| Net Margin | 36.5% | 23.6% | -8.4% | -41.8% | -34.7% | -63.7% | -69.4% | -109.6% | -231.7% | -1565.9% | -269578.7% | -77062.5% | |
| Pretax Margin | 13.0% | 26.9% | -7.0% | -41.3% | -34.6% | -63.6% | -69.1% | -109.0% | -230.8% | -1558.2% | -269037.7% | · | |
| EBITDA Margin | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% | -64.9% | -72.7% | -110.6% | -234.1% | -1574.1% | -269855.7% | -77691.7% | |
| ROA | 28.4% | 23.4% | -9.2% | -33.5% | -22.6% | -36.0% | -35.5% | -53.0% | -61.2% | -69.3% | -60.1% | -35.9% | |
| ROE | 38.1% | 34.6% | -15.4% | -52.3% | -30.3% | -43.9% | -33.9% | -69.8% | -67.8% | -75.6% | -64.6% | -37.6% | |
| ROIC | 24.0% | 27.6% | -20.4% | -56.5% | -31.6% | -45.8% | -35.4% | -51.9% | -87.5% | -52.9% | -82.6% | · |
Likidite ve Solventlik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 2.4 | 2.4 | 4.0 | 6.4 | 6.8 | 10.2 | 8.8 | 7.6 | 12.9 | 10.0 | 20.5 | |
| Quick Ratio | 1.1 | 1.1 | 1.1 | 1.4 | 2.2 | 3.5 | 3.0 | 2.7 | 1.8 | 4.0 | 4.7 | 3.9 |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 1.0 | 1.1 | 0.8 | 0.7 | 0.6 | 0.5 | 0.5 | 0.3 | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | 0.9 | 1.2 | 1.6 | 0.8 | 0.9 | 1.3 | 2.2 | · | 1.9 | 1.5 | · | · | |
| Receivables Turnover | 9.7 | 9.7 | 9.1 | 8.2 | 8.6 | 10.5 | 11.0 | 10.3 | 10.7 | 5.9 | · | · |
Büyüme Oranları 5
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.9% | 31.9% | 40.5% | 6.8% | 9.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 27.5% | 25.5% | 18.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 19.4% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 69.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 72.7% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 10
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.07B | $958M | $726M | $517M | $484M | $442M | $339M | $224M | $125M | $17M | $61.0K | $120.0K | |
| Net Income TTM | $391M | $226M | $-61M | $-216M | $-168M | $-282M | $-235M | $-245M | $-289M | $-271M | $-164M | $-92M | |
| Market Cap | $4.55B | $3.06B | $5.16B | $2.58B | $3.76B | $8.53B | $6.64B | $2.33B | $3.75B | $3.50B | $3.63B | $3.18B | |
| P/E | 11.6 | 13.5 | -84.6 | -11.9 | -22.2 | -29.9 | · | · | · | · | · | · | |
| P/S | 4.2 | 3.2 | 7.1 | 5.0 | 7.8 | 19.3 | 19.6 | 10.4 | 30.0 | 202.0 | 59575.7 | 26470.9 | |
| P/B | 3.7 | 4.2 | 11.9 | 6.4 | 6.9 | 13.6 | 9.5 | 4.9 | 11.2 | 6.8 | 18.2 | 10.3 | |
| P / Tangible Book | 4.1 | 5.0 | 14.1 | 6.4 | 6.9 | 13.6 | · | · | · | · | · | · | |
| P / Cash Flow | 41.4 | 19.4 | 308.7 | -22.6 | -29.9 | -62.7 | -44.0 | -13.9 | -17.2 | -16.6 | -29.8 | -47.8 | |
| P / FCF | 43.3 | 19.5 | 309.6 | -22.6 | -29.6 | -59.4 | -43.6 | -13.7 | -17.1 | -16.5 | -29.3 | -47.7 | |
| Earnings Yield | 8.6% | 7.4% | -1.2% | -8.4% | -4.5% | -3.4% | · | · | · | · | · | · |
Gelir Tablosu 16
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $308M | $268M | $284M | $279M | $265M | $244M | $260M | $250M | $242M | $206M | $231M | $212M | $165M | $118M | $136M | $131M | |
| Cost of Revenue | $28M | $25M | $26M | $22M | $21M | $20M | $22M | $19M | $18M | $23M | $18M | $15M | $7M | $2M | $2M | $2M | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | $213M | $197M | $158M | $117M | $134M | $129M | |
| R&D Expense | $82M | $77M | $85M | $88M | $78M | $78M | $101M | $67M | $76M | $60M | $67M | $157M | $59M | $69M | $76M | $81M | |
| SG&A Expense | $160M | $171M | $156M | $133M | $134M | $126M | $130M | $133M | $117M | $108M | $111M | $98M | $96M | $101M | $104M | $78M | |
| Operating Expenses | $270M | $273M | $267M | $243M | $232M | $225M | $106M | $219M | $212M | $191M | $196M | $269M | $162M | $172M | $183M | $162M | |
| Operating Income | $38M | $-5M | $17M | $36M | $32M | $19M | $154M | $32M | $30M | $15M | $35M | $-58M | $3M | $-54M | $-46M | $-31M | |
| Other Non-op | $647.0K | $542.0K | $596.0K | $593.0K | $594.0K | $588.0K | $575.0K | $576.0K | $386.0K | $286.0K | $0 | $2M | $-1M | $5M | $2M | $2M | |
| Pretax Income | $46M | $4M | $26M | $45M | $40M | $28M | $161M | $39M | $37M | $21M | $40M | $-52M | $6M | $-45M | $-41M | $-26M | |
| Income Tax | $15M | $344.0K | $-247M | $-27M | $14M | $9M | $17M | $6M | $4M | $4M | $-6M | $13M | $5M | $-2M | $835.0K | $768.0K | |
| Net Income | $32M | $4M | $274M | $72M | $27M | $19M | $144M | $33M | $33M | $17M | $46M | $-65M | $1M | $-43M | $-42M | $-27M | |
| EPS (Basic) | $0.18 | $0.02 | $1.62 | $0.43 | $0.16 | $0.11 | $0.87 | $0.20 | $0.20 | $0.10 | $0.29 | $-0.40 | $0.01 | $-0.27 | $-0.26 | $-0.17 | |
| EPS (Diluted) | $0.18 | $0.02 | $1.61 | $0.42 | $0.16 | $0.11 | $0.86 | $0.20 | $0.20 | $0.10 | $0.29 | $-0.40 | $0.01 | $-0.27 | $-0.26 | $-0.17 | |
| Shares (Basic) | 171,603,000 | 170,517,000 | -335,115,000 | 168,836,000 | 167,827,000 | 166,808,000 | -330,606,000 | 165,974,000 | 165,551,000 | 164,798,000 | -326,136,000 | 164,234,000 | 163,458,000 | 162,263,000 | 128,494 | 161,852 | |
| Shares (Diluted) | 172,851,000 | 172,706,000 | -337,080,000 | 170,650,000 | 168,681,000 | 167,668,000 | -332,613,000 | 166,178,000 | 166,174,000 | 166,623,000 | -327,724,000 | 164,234,000 | 165,046,000 | 162,263,000 | 128,494 | 161,852 | |
| EBITDA | $38M | $-5M | · | $36M | $32M | $19M | · | $32M | $30M | $15M | · | $-58M | $3M | $-54M | · | $-31M |
Bilanço 24
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $385M | $282M | $178M | $258M | $254M | $218M | $320M | $155M | $177M | $205M | $189M | $98M | $108M | $291M | $115M | $155M | |
| Receivables | $151M | $135M | $121M | $116M | $108M | $106M | $99M | $98M | $104M | $95M | · | $93M | $82M | $66M | · | $56M | |
| Inventory | $109M | $112M | $111M | $106M | $111M | $103M | $92M | $87M | $86M | $67M | · | $25M | $14M | $11M | · | $12M | |
| Prepaid Expense | $69M | $65M | $60M | $61M | $53M | $53M | $56M | $52M | $46M | $43M | · | $38M | $24M | $24M | · | $23M | |
| Current Assets | $1.22B | $1.10B | $1.06B | $1.08B | $961M | $871M | $938M | $788M | $729M | $675M | · | $499M | $493M | $503M | · | $522M | |
| PP&E (Net) | $17M | $15M | $8M | $4M | $4M | $3M | $4M | $4M | $4M | $4M | · | $5M | $5M | $6M | · | $7M | |
| PP&E (Gross) | · | · | $17M | · | · | · | $14M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $9M | · | · | · | $10M | · | · | · | · | · | · | · | · | · | |
| Intangibles | $103M | $106M | $109M | $112M | $114M | $117M | $120M | $106M | $108M | $110M | · | $67M | $68M | $70M | · | · | |
| Other Non-current Assets | $4M | $4M | $4M | $3M | $2M | $1M | $359.0K | $359.0K | $476.0K | $476.0K | · | $475.0K | $11M | $12M | · | $6M | |
| Total Assets | $1.74B | $1.61B | $1.56B | $1.33B | $1.23B | $1.13B | $1.19B | $977M | $914M | $855M | · | $633M | $643M | $655M | · | $602M | |
| Accounts Payable | $45M | $12M | $11M | $22M | $20M | $18M | $16M | $19M | $20M | $19M | · | $12M | $19M | $17M | · | $10M | |
| Accrued Liabilities | $317M | $293M | $266M | $335M | $310M | $284M | $379M | $325M | $318M | $311M | · | $197M | $169M | $207M | · | $107M | |
| Current Liabilities | $361M | $306M | $277M | $357M | $330M | $303M | $395M | $344M | $338M | $331M | · | $210M | $188M | $224M | · | $117M | |
| Capital Leases | $60M | $39M | $41M | $43M | $45M | $45M | $42M | $40M | $47M | $49M | · | $48M | $50M | $51M | · | $54M | |
| Deferred Tax | · | · | $11M | · | · | · | $11M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $15M | $13M | $19M | $14M | $29M | $20M | $18M | $15M | $12M | $11M | · | $13M | $9M | $5M | · | $6M | |
| Total Liabilities | $436M | $357M | $337M | $413M | $403M | $367M | $455M | $400M | $397M | $391M | · | $270M | $247M | $281M | · | $177M | |
| Common Stock | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | · | $16.0K | $16.0K | $16.0K | · | $16.0K | |
| Retained Earnings | $-1.78B | $-1.81B | $-1.81B | $-2.09B | $-2.16B | $-2.19B | $-2.20B | $-2.35B | $-2.38B | $-2.41B | · | $-2.48B | $-2.41B | $-2.41B | · | $-2.33B | |
| AOCI | $-958.0K | $-563.0K | $1M | $989.0K | $406.0K | $437.0K | $292.0K | $858.0K | $-339.0K | $-229.0K | · | $-319.0K | $-535.0K | $-220.0K | · | $-1M | |
| Stockholders' Equity | $1.31B | $1.25B | $1.23B | $917M | $822M | $765M | $733M | $577M | $517M | $464M | $432M | $362M | $396M | $374M | $400M | $426M | |
| Liabilities + Equity | $1.74B | $1.61B | $1.56B | $1.33B | $1.23B | $1.13B | $1.19B | $977M | $914M | $855M | · | $633M | $643M | $655M | · | $602M | |
| Shares Outstanding | 172,132,442 | 171,086,205 | 170,309,376 | 169,146,043 | 168,607,881 | 167,116,045 | 166,708,856 | 166,351,715 | 165,853,301 | 164,959,736 | · | 163,968,949 | 163,355,787 | 162,384,178 | · | 161,871,806 |
Nakit Akışı 10
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $17M | $15M | $13M | $13M | $14M | $11M | $10M | $26M | $16M | $15M | $18M | $19M | $15M | $15M | $14M | $18M | |
| Amort. of Intangibles | $3M | $3M | $3M | $3M | $3M | $3M | $5M | $2M | $2M | $5M | $1M | $1M | $1M | $0 | $0 | $0 | |
| Operating Cash Flow | $101M | $34M | $-49M | $74M | $64M | $20M | $40M | $63M | $25M | $29M | $85M | $-59M | $8M | $-18M | $-24M | $-727.0K | |
| CapEx | $5M | $5M | $4M | $388.0K | $297.0K | $0 | $453.0K | $70.0K | · | · | $0 | · | · | · | $0 | $0 | |
| Investing Cash Flow | $-9M | $66M | $-56M | $-79M | $-43M | $-124M | $122M | $-82M | $-56M | $-14M | $-347.0K | $34M | $-194M | $193M | $-18M | $15M | |
| Stock Issued | $10M | $4M | $23M | $9M | $16M | $2M | $2M | $268.0K | $4M | $1M | $5M | $13M | $5M | $1M | $2M | $287.0K | |
| Net Stock Activity | · | $4M | · | · | · | $2M | · | · | · | $1M | · | · | · | $1M | · | · | |
| Financing Cash Flow | $10M | $4M | $23M | $9M | $16M | $2M | $2M | $268.0K | $4M | $1M | $5M | $13M | $5M | $1M | $2M | $287.0K | |
| Net Change in Cash | $103M | $105M | $-82M | $4M | $37M | $-102M | $164M | $-19M | $-28M | $16M | $90M | $-12M | $-181M | $176M | $-40M | $15M | |
| Free Cash Flow | · | $29M | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Kârlılık 7
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 12.3% | -1.7% | · | 12.8% | 12.2% | 7.9% | · | 12.6% | 12.6% | 7.4% | · | -27.3% | 1.8% | -45.2% | · | -23.6% | |
| Net Margin | 10.2% | 1.4% | · | 25.8% | 10.1% | 7.8% | · | 13.1% | 13.8% | 8.0% | · | -30.8% | 0.67% | -36.3% | · | -20.8% | |
| Pretax Margin | 15.1% | 1.5% | · | 16.0% | 15.2% | 11.4% | · | 15.5% | 15.4% | 10.2% | · | -24.6% | 3.8% | -37.9% | · | -20.2% | |
| EBITDA Margin | 12.3% | -1.7% | · | 12.8% | 12.2% | 7.9% | · | 12.6% | 12.6% | 7.4% | · | -27.3% | 1.8% | -45.2% | · | -23.6% | |
| ROA | 2.1% | 0.27% | · | 6.2% | 2.5% | 1.9% | · | 4.1% | 4.3% | 2.2% | · | -10.5% | 0.18% | -6.7% | · | -4.1% | |
| ROE | 3.0% | 0.36% | · | 9.6% | 4.0% | 3.1% | · | 7.0% | 7.3% | 4.0% | · | -16.6% | 0.27% | -10.5% | · | -5.5% | |
| ROIC | 2.0% | -0.34% | · | 6.3% | 2.6% | 1.7% | · | 4.6% | 5.3% | 2.6% | · | -19.9% | 0.13% | -13.7% | · | -7.5% |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 3.6 | · | 3.0 | 2.9 | 2.9 | · | 2.3 | 2.2 | 2.0 | · | 2.4 | 2.6 | 2.2 | · | 4.5 | |
| Quick Ratio | 1.5 | 1.4 | · | 1.0 | 1.1 | 1.1 | · | 0.7 | 0.8 | 0.9 | · | 0.9 | 1.0 | 1.6 | · | 1.8 |
Verimlilik 3
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.4 | 0.6 | · | 0.8 | 0.6 | 0.1 | · | 0.2 | |
| Receivables Turnover | 2.4 | 2.2 | · | 2.6 | 2.5 | 2.4 | · | 2.6 | 2.6 | 2.6 | · | 2.9 | 2.2 | 1.8 | · | 2.2 |
Değerleme (TTM) 10
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.12B | $1.06B | · | $1.04B | $1.00B | $943M | · | $929M | $891M | $814M | · | $632M | $551M | $520M | · | $512M | |
| Net Income TTM | $134M | $121M | · | $150M | $112M | $102M | · | $129M | $31M | $-2M | · | $-149M | $-111M | $-146M | · | $-217M | |
| Market Cap | $4.35B | $3.81B | · | $3.61B | $3.64B | $2.78B | · | $2.56B | $2.70B | $3.05B | · | $3.42B | $3.91B | $3.06B | · | $2.65B | |
| P/E | 32.4 | 31.4 | · | 24.0 | 32.2 | 27.2 | · | 19.7 | 90.3 | -1849.0 | · | -22.7 | -34.7 | -20.7 | · | -12.1 | |
| P/S | 3.9 | 3.6 | · | 3.5 | 3.6 | 2.9 | · | 2.8 | 3.0 | 3.7 | · | 5.4 | 7.1 | 5.9 | · | 5.2 | |
| P/B | 3.3 | 3.1 | · | 3.9 | 4.4 | 3.6 | · | 4.4 | 5.2 | 6.6 | · | 9.4 | 9.9 | 8.2 | · | 6.2 | |
| P / Tangible Book | 3.6 | 3.3 | · | 4.5 | 5.1 | 4.3 | · | 5.4 | 6.6 | 8.6 | · | 11.6 | 11.9 | 10.0 | · | 6.2 | |
| P / Cash Flow | · | 112.1 | · | · | · | 136.6 | · | · | · | 104.9 | · | · | · | -170.4 | · | · | |
| P / FCF | · | 132.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 3.1% | 3.2% | · | 4.2% | 3.1% | 3.7% | · | 5.1% | 1.1% | -0.05% | · | -4.4% | -2.9% | -4.8% | · | -8.2% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $1.07B | $958M | $726M | $517M | $484M |
| Brüt Kâr Marjı % | — | — | 94.3% | 98.0% | 97.8% |
| Faaliyet Kâr Marjı % | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% |
| Net Gelir | $391M | $226M | $-61M | $-216M | $-168M |
| Seyreltilmiş Hisse Başı Kâr | $2.30 | $1.36 | $-0.37 | $-1.34 | $-1.05 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 3.8 | 2.4 | 2.4 | 4.0 | 6.4 |
| Cari Oran | 1.1 | 1.1 | 1.1 | 1.4 | 2.2 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $105M | $157M | $17M | $-114M | $-127M |
Son Haberler Bu şirketten bahseden son manşetler
İşlem Sinyalleri Giriş fiyatı ve risk/ödül oranı ile son alım/satım sinyalleri
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 388 dosya · $3.3B toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 56 (+10 önceki Ç'ye göre) | 37 (+10 önceki Ç'ye göre) | 136 (+11 önceki Ç'ye göre) | 100 (-13 önceki Ç'ye göre) | +17.3M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $1.085.696.471 | 42.912.904 | 32,71% | Hisse senetleri |
| STATE STREET CORP | $229.628.164 | 9.076.212 | 6,92% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $223.612.785 | 8.838.450 | 6,74% | Hisse senetleri |
| RTW INVESTMENTS, LP | $180.756.457 | 7.144.524 | 5,45% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $145.822.875 | 5.763.750 | 4,39% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $88.971.384 | 3.516.656 | 2,68% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $73.088.127 | 2.888.204 | 2,20% | Hisse senetleri |
| Palo Alto Investors LP | $72.461.629 | 2.864.096 | 2,18% | Hisse senetleri |
| Qube Research & Technologies Ltd | $61.899.233 | 2.446.610 | 1,86% | Hisse senetleri |
| Point72 Asset Management, L.P. | $61.559.150 | 2.433.168 | 1,85% | Hisse senetleri |
| CITADEL ADVISORS LLC | $53.414.195 | 2.111.233 | 1,61% | Hisse senetleri |
| Pictet Asset Management Holding SA | $50.146.450 | 1.983.198 | 1,51% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $49.826.959 | 1.969.445 | 1,50% | Hisse senetleri |
| MARSHALL WACE, LLP | $44.649.289 | 1.764.794 | 1,35% | Hisse senetleri |
| BRAIDWELL LP | $41.653.895 | 1.646.399 | 1,25% | Hisse senetleri |
| NORGES BANK | $41.069.692 | 1.623.308 | 1,24% | Hisse senetleri |
| Frazier Life Sciences Management, L.P. | $36.386.409 | 1.438.198 | 1,10% | Hisse senetleri |
| Artisan Partners Limited Partnership | $33.525.890 | 1.325.134 | 1,01% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $32.449.679 | 1.282.596 | 0,98% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $32.070.584 | 1.267.612 | 0,97% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $30.520.301 | 1.206.336 | 0,92% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $28.330.257 | 1.119.773 | 0,85% | Hisse senetleri |
| Allspring Global Investments Holdings, LLC | $26.143.513 | 1.037.441 | 0,79% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $23.452.898 | 926.992 | 0,71% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $23.082.961 | 912.370 | 0,70% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $21.702.062 | 857.789 | 0,65% | Hisse senetleri |
| PANAGORA ASSET MANAGEMENT INC | $17.985.922 | 710.906 | 0,54% | Hisse senetleri |
| Fisher Asset Management, LLC | $17.690.535 | 699.230 | 0,53% | Hisse senetleri |
| Allianz Asset Management GmbH | $15.730.341 | 706.664 | 0,47% | Hisse senetleri |
| RICE HALL JAMES & ASSOCIATES, LLC | $15.657.841 | 618.887 | 0,47% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $14.925.077 | 589.924 | 0,45% | Hisse senetleri |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $14.771.456 | 583.852 | 0,45% | Hisse senetleri |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $12.903.000 | 510.000 | 0,39% | Hisse senetleri |
| Hudson Bay Capital Management LP | $11.764.500 | 465.000 | 0,35% | Hisse senetleri |
| GLENMEDE TRUST CO NA | $11.656.544 | 460.733 | 0,35% | Hisse senetleri |
| JUPITER ASSET MANAGEMENT LTD | $11.599.190 | 458.466 | 0,35% | Hisse senetleri |
| Public Sector Pension Investment Board | $11.014.988 | 435.375 | 0,33% | Hisse senetleri |
| MACKENZIE FINANCIAL CORP | $10.646.872 | 420.825 | 0,32% | Hisse senetleri |
| Ishara Investments LP | $10.373.000 | 410.000 | 0,31% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $9.888.042 | 370.200 | 0,30% | Hisse senetleri |
| Balyasny Asset Management L.P. | $9.817.007 | 388.024 | 0,30% | Hisse senetleri |
| BlackRock, Inc. | $9.281.482 | 366.857 | 0,28% | Hisse senetleri |
| SPHERA FUNDS MANAGEMENT LTD. | $9.020.310 | 356.534 | 0,27% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $8.039.177 | 317.754 | 0,24% | Hisse senetleri |
| PRUDENTIAL FINANCIAL INC | $7.985.313 | 315.625 | 0,24% | Hisse senetleri |
| Alyeska Investment Group, L.P. | $7.850.261 | 310.287 | 0,24% | Hisse senetleri |
| RHUMBLINE ADVISERS | $7.663.389 | 302.902 | 0,23% | Hisse senetleri |
| Schonfeld Strategic Advisors LLC | $7.189.171 | 284.157 | 0,22% | Hisse senetleri |
| Edgestream Partners, L.P. | $7.167.515 | 283.301 | 0,22% | Hisse senetleri |
| Logos Global Management LP | $6.325.000 | 250.000 | 0,19% | Hisse senetleri |
| LAZARD ASSET MANAGEMENT LLC | $6.263.496 | 247.569 | 0,19% | Hisse senetleri |
| FMR LLC | $6.052.317 | 239.222 | 0,18% | Hisse senetleri |
| Swiss National Bank | $5.841.871 | 230.904 | 0,18% | Hisse senetleri |
| VICTORY CAPITAL MANAGEMENT INC | $5.432.213 | 214.712 | 0,16% | Hisse senetleri |
| ALPS ADVISORS INC | $4.985.340 | 197.049 | 0,15% | Hisse senetleri |
| ENVESTNET ASSET MANAGEMENT INC | $4.926.239 | 194.713 | 0,15% | Hisse senetleri |
| Legal & General Group Plc | $4.918.245 | 194.397 | 0,15% | Hisse senetleri |
| FIRST TRUST ADVISORS LP | $4.664.965 | 184.386 | 0,14% | Hisse senetleri |
| NEW YORK STATE COMMON RETIREMENT FUND | $4.364.807 | 172.522 | 0,13% | Hisse senetleri |
| Birchview Capital, LP | $4.326.300 | 171.000 | 0,13% | Hisse senetleri |
| MARTINGALE ASSET MANAGEMENT L P | $4.247.693 | 167.893 | 0,13% | Hisse senetleri |
| Tetragon Partners GP Ltd | $4.247.238 | 167.875 | 0,13% | Hisse senetleri |
| GREAT LAKES ADVISORS, LLC | $3.822.526 | 151.088 | 0,12% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $3.635.306 | 143.688 | 0,11% | Hisse senetleri |
| STEMPOINT CAPITAL LP | $3.622.125 | 143.167 | 0,11% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $3.585.329 | 161.066 | 0,11% | Hisse senetleri |
| Squarepoint Ops LLC | $3.542.329 | 140.013 | 0,11% | Hisse senetleri |
| ORBIMED ADVISORS LLC | $3.466.100 | 137.000 | 0,10% | Hisse senetleri |
| Erste Asset Management GmbH | $3.369.240 | 133.700 | 0,10% | Hisse senetleri |
| Emerald Investment Advisers, LLC | $3.333.326 | 131.752 | 0,10% | Hisse senetleri |
| Caption Management, LLC | $3.289.000 | 130.000 | 0,10% | Satım opsiyonu |
| VANGUARD ASSET MANAGEMENT, Ltd | $3.130.217 | 123.724 | 0,09% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $3.084.475 | 121.916 | 0,09% | Hisse senetleri |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $3.077.311 | 138.244 | 0,09% | Hisse senetleri |
| Longaeva Partners L.P. | $2.968.145 | 117.318 | 0,09% | Hisse senetleri |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2.948.791 | 116.553 | 0,09% | Hisse senetleri |
| Trexquant Investment LP | $2.935.357 | 116.022 | 0,09% | Hisse senetleri |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $2.909.778 | 115.011 | 0,09% | Hisse senetleri |
| JONES FINANCIAL COMPANIES LLLP | $2.868.477 | 113.289 | 0,09% | Hisse senetleri |
| Rafferty Asset Management, LLC | $2.789.426 | 110.254 | 0,08% | Hisse senetleri |
| Nan Fung Group Holdings Ltd | $2.605.495 | 102.984 | 0,08% | Hisse senetleri |
| RAYMOND JAMES FINANCIAL INC | $2.406.232 | 95.108 | 0,07% | Hisse senetleri |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $2.344.000 | 92.648 | 0,07% | Hisse senetleri |
| ROYCE & ASSOCIATES LP | $2.324.691 | 91.885 | 0,07% | Hisse senetleri |
| HOHIMER WEALTH MANAGEMENT, LLC | $2.322.540 | 91.800 | 0,07% | Hisse senetleri |
| Point72 Europe (London) LLP | $2.305.047 | 108.015 | 0,07% | Hisse senetleri |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $2.134.076 | 79.898 | 0,06% | Hisse senetleri |
| Campbell & CO Investment Adviser LLC | $2.108.527 | 83.341 | 0,06% | Hisse senetleri |
| Verdad Advisers, LP | $2.090.514 | 82.629 | 0,06% | Hisse senetleri |
| VOYA INVESTMENT MANAGEMENT LLC | $2.072.576 | 81.920 | 0,06% | Hisse senetleri |
| CITADEL ADVISORS LLC | $2.049.300 | 81.000 | 0,06% | Alım opsiyonu |
| GUGGENHEIM CAPITAL LLC | $1.979.776 | 78.252 | 0,06% | Hisse senetleri |
| WESBANCO BANK INC | $1.978.460 | 78.200 | 0,06% | Hisse senetleri |
| Phocas Financial Corp. | $1.954.299 | 77.245 | 0,06% | Hisse senetleri |
| MetLife Investment Management, LLC | $1.899.043 | 75.061 | 0,06% | Hisse senetleri |
| STATE OF WISCONSIN INVESTMENT BOARD | $1.850.493 | 73.142 | 0,06% | Hisse senetleri |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1.788.331 | 70.685 | 0,05% | Hisse senetleri |
| Freestone Grove Partners LP | $1.755.643 | 69.393 | 0,05% | Hisse senetleri |
| CenterBook Partners LP | $1.743.878 | 68.928 | 0,05% | Hisse senetleri |
| CANADA PENSION PLAN INVESTMENT BOARD | $1.722.930 | 68.100 | 0,05% | Hisse senetleri |
Şirket yöneticileri 37 içeriden öğrenenler · 19 yöneticiler · 19 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Stephen Davis | CEO | 06 Ocak 2024 M | 96.521 | 0 | 0 | $0 |
| Uli Hacksell | CEO | 25 Mart 2011 A | 69.916 | 0 | 0 | $0 |
| Elena Ridloff | EVP and CFO | 29 Nisan 2021 M | 10.553 | 0 | 0 | $0 |
| Todd S. Young | EVP AND CFO | 15 Ekim 2018 A | — | 0 | 0 | $0 |
| Thomas H Aasen | Exec. VP, CFO & CBO | 25 Mart 2011 A | 13.899 | 0 | 0 | $0 |
| Srdjan R. Stankovic | President | 21 Kasım 2022 M | 61.234 | 0 | 0 | $0 |
| Mark R Brann | President & CSO | 16 Haziran 2006 S | 317.756 | 0 | 0 | $0 |
| Brendan Teehan | EVP, COO, Head of Commercial | 06 Ocak 2024 M | 30.949 | 0 | 0 | $0 |
| Elizabeth H.Z. Thompson | EVP, Head of Research & Dev | 29 Temmuz 2026 M | 18.994 | 0 | 2 | $-432.662 |
| James Kihara | PRINCIPAL ACCOUNTING OFFICER | 26 Haziran 2026 S | 13.088 | 0 | 2 | $-412.253 |
| Austin D. Kim | EVP,General Counsel, Secretary | 06 Ocak 2024 M | 46.901 | 0 | 0 | $0 |
| Douglas J Williamson | Executive VP, Research & Dev | 10 Şubat 2023 A | — | 0 | 0 | $0 |
| Michael J. Yang | EVP and CCO | 06 Ocak 2021 M | 8.059 | 0 | 0 | $0 |
| Eric Alejandro Miller | Controller & PAO | 15 Ekim 2019 M | 270 | 0 | 0 | $0 |
| Glenn Baity | VP, GC & Sec. | 25 Mart 2011 A | — | 0 | 0 | $0 |
| Roger Mills | Executive VP, Development | 25 Mart 2011 A | — | 0 | 0 | $0 |
| Bo-Ragnar Tolf | VP/Mg. Dir. ACADIA Pharma AB | 08 Temmuz 2009 M | 20.000 | 0 | 0 | $0 |
| Brian Lundstrom | Sr. VP, Bus. Development | 07 Mart 2008 A | 0 | 0 | 0 | $0 |
| Robert E Davis | Exec. VP, Drug Discovery | 11 Mart 2005 A | — | 0 | 0 | $0 |
| Adora Ndu | Yönetim kurulu üyesi | 29 Mayıs 2026 A | 32.908 | 0 | 0 | $0 |
| Elizabeth A. Garofalo | Yönetim kurulu üyesi | 29 Mayıs 2026 A | 33.489 | 0 | 0 | $0 |
| Jonathan Poole | Yönetim kurulu üyesi | 29 Mayıs 2026 A | 2.010 | 0 | 0 | $0 |
| James M Daly | Yönetim kurulu üyesi | 29 Mayıs 2026 A | 12.148 | 0 | 0 | $0 |
| Laura Brege | Yönetim kurulu üyesi | 29 Mayıs 2026 A | 23.202 | 0 | 0 | $0 |
| Edmund Harrigan | Yönetim kurulu üyesi | 29 Mayıs 2026 A | 43.148 | 0 | 0 | $0 |
| Daniel B Soland | Yönetim kurulu üyesi | 01 Haziran 2023 A | 28.002 | 0 | 0 | $0 |
| Torsten Rasmussen | Yönetim kurulu üyesi | 11 Haziran 2010 A | 4.000 | 0 | 0 | $0 |
| Leslie L Iversen | Yönetim kurulu üyesi | 11 Haziran 2010 A | 9.000 | 0 | 0 | $0 |
| Mary Ann Gray | Yönetim kurulu üyesi | 11 Haziran 2010 A | — | 0 | 0 | $0 |
| Michael T Borer | Yönetim kurulu üyesi | 11 Haziran 2010 A | — | 0 | 0 | $0 |
| Lester J Ph D Kaplan | Yönetim kurulu üyesi | 11 Haziran 2010 A | 4.000 | 0 | 0 | $0 |
| Gordon M Binder | Yönetim kurulu üyesi | 12 Haziran 2009 A | 14.364 | 0 | 0 | $0 |
| Alan G Walton | Yönetim kurulu üyesi | 12 Haziran 2009 A | 25.979 | 0 | 0 | $0 |
| Martien Van Osch | Yönetim kurulu üyesi | 10 Haziran 2005 A | 1.168.892 | 0 | 0 | $0 |
| GORDON CARL L | Yönetim kurulu üyesi | 20 Nisan 2005 A | 774.006 | 0 | 0 | $0 |
| Mark C. Schneyer | — | 06 Ağustos 2026 M | 67.828 | 0 | 3 | $-587.248 |
| John Joseph Kaiser | — | 20 Ekim 2008 A | — | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 6 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker, FBB3 LLC ×14 başvurular | 26 Şubat 2026 | 25,40% | Değişiklik | — | SEC |
| Baker Bros. Advisors, LLC, Felix J. Baker, Julian C. Baker ×4 başvurular | 06 Haziran 2013 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 02 Mayıs 2005 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 02 Mayıs 2005 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 02 Mayıs 2005 | — | İlk başvuru | — | SEC |
| Oxford Bioscience Partners IV L.P., mRNA Fund II L.P., OBP Management IV L.P., Jeffrey T. Barnes, Mark P. Carthy, Jonathan J. Fleming, Michael E. Lytton, Alan G. Walton | 29 Nisan 2005 | — | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 77 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IBRN · iShares Trust | 4,89% | 13.265 SH | 08 Ağustos 2026 | Günlük |
| PBE · Invesco Exchange-Traded Fund Trust | 3,29% | 407.914 SH | 08 Ağustos 2026 | Günlük |
| SBIO · ALPS ETF Trust | 2,35% | 175.740 NS | 31 Mayıs 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,87% | 109.972 SH | 08 Ağustos 2026 | Günlük |
| BBP · ETFis Series Trust I | 1,32% | 34.855 NS | 30 Nisan 2026 | N-PORT |
| RZG · Invesco Exchange-Traded Fund Trust | 1,25% | 59.514 SH | 08 Ağustos 2026 | Günlük |
| LABU · Direxion Shares ETF Trust | 0,85% | 195.542 NS | 30 Nisan 2026 | N-PORT |
| ROSC · Lattice Strategies Trust | 0,56% | 13.607 NS | 30 Nisan 2026 | N-PORT |
| IJT · iShares Trust | 0,40% | 1.176.933 SH | 08 Ağustos 2026 | Günlük |
| OASC · Unified Series Trust | 0,39% | 15.269 NS | 31 Mayıs 2026 | N-PORT |
| IBB · iShares Trust | 0,37% | 1.239.145 SH | 08 Ağustos 2026 | Günlük |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,35% | 150.827 SH | 08 Ağustos 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,34% | 9.317 SH | 08 Ağustos 2026 | Günlük |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,27% | 61.606 NS | 30 Nisan 2026 | N-PORT |
| BFOR · ALPS ETF Trust | 0,24% | 24.003 NS | 31 Mayıs 2026 | N-PORT |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,23% | 20.369 SH | 08 Ağustos 2026 | Günlük |
| IWO · iShares Trust | 0,23% | 1.166.817 SH | 08 Ağustos 2026 | Günlük |
| XJR · iShares Trust | 0,23% | 14.974 SH | 08 Ağustos 2026 | Günlük |
| GSSC · Goldman Sachs ETF Trust | 0,20% | 89.945 NS | 31 Mayıs 2026 | N-PORT |
| IJR · iShares Trust | 0,20% | 7.728.433 SH | 08 Ağustos 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,19% | 137.860 SH | 08 Ağustos 2026 | Günlük |
| BIB · ProShares Trust | 0,19% | 6.303 NS | 31 Mayıs 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,17% | 443.221 SH | 08 Ağustos 2026 | Günlük |
| BKSE · BNY Mellon ETF Trust | 0,17% | 6.035 NS | 30 Nisan 2026 | N-PORT |
| SMMV · iShares Trust | 0,17% | 17.063 SH | 08 Ağustos 2026 | Günlük |
| SMLF · iShares Trust | 0,15% | 219.745 SH | 08 Ağustos 2026 | Günlük |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,15% | 47.683 NS | 30 Nisan 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,14% | 137.072 SH | 08 Ağustos 2026 | Günlük |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,14% | 81.552 NS | 30 Nisan 2026 | N-PORT |
| SAA · ProShares Trust | 0,12% | 1.498 NS | 31 Mayıs 2026 | N-PORT |
| IWM · iShares Trust | 0,12% | 3.281.125 SH | 08 Ağustos 2026 | Günlük |
| ISCG · iShares Trust | 0,11% | 39.884 SH | 08 Ağustos 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,10% | 741.237 SH | 08 Ağustos 2026 | Günlük |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,09% | 66.331 SH | 08 Ağustos 2026 | Günlük |
| VBK · VANGUARD INDEX FUNDS | 0,09% | 1.699.377 SH | 08 Ağustos 2026 | Günlük |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,09% | 115.210 NS | 31 Mayıs 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,08% | 526.641 NS | 30 Nisan 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,08% | 16.957 NS | 30 Nisan 2026 | N-PORT |
| ITWO · ProShares Trust | 0,07% | 5.921 NS | 31 Mayıs 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,06% | 599.784 NS | 31 Mayıs 2026 | N-PORT |
| ISCB · iShares Trust | 0,06% | 5.636 SH | 08 Ağustos 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 54.956 NS | 30 Nisan 2026 | N-PORT |
| IEUS · iShares Trust | 0,04% | 7.411 SH | 08 Ağustos 2026 | Günlük |
| SMDX · Tidal Trust III | 0,04% | 2.306 NS | 30 Nisan 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,04% | 4.033 SH | 08 Ağustos 2026 | Günlük |
| UWM · ProShares Trust | 0,04% | 4.631 NS | 31 Mayıs 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,04% | 1.457.036 SH | 08 Ağustos 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | 0,04% | 2.944.095 SH | 08 Ağustos 2026 | Günlük |
| PDN · Invesco Exchange-Traded Fund Trust … | 0,04% | 14.209 SH | 08 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,04% | 346.329 SH | 08 Ağustos 2026 | Günlük |